Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · AtriCure, Inc. (ATRC)

AtriCure Q2 revenue rises 12.8% to $153.6 million; swings to $9.0 million profit

Positive Impact 3 of 5 earnings Written later

AtriCure reported second quarter 2026 revenue of $153.6 million, up 12.8% from a year earlier, and net income of $9.0 million, compared with a net loss of $6.2 million in the same quarter of 2025. The company also issued full-year 2026 guidance of $602 million to $610 million in revenue and $0.05 to $0.13 in net income per share, which shareholders can compare with future results.

Key points

  • Q2 2026 revenue was $153.6 million, up from $136.1 million in Q2 2025; U.S. revenue rose 13.6% to $125.6 million.
  • Net income was $9.0 million, or $0.18 per diluted share, versus a net loss of $6.2 million, or $0.13 per share, a year earlier.
  • Adjusted EBITDA was $27.3 million, an increase of $11.9 million or 78% from Q2 2025.
  • 2026 guidance: revenue of approximately $602 million to $610 million and net income per share of $0.05 to $0.13.

The filing

CompanyAtriCure, Inc. (ATRC)
Form8-K, current report
Filed with the SECJul 23, 2026, 4:00 PM ET
Accession number0001323885-26-000032

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.